We have been monitoring the requirements across the supply chain from supplier through to patient for some time. There are clear supply chain plans in place for both the supply and onward deployment of all vaccine candidates. This includes materials, manufacturing, transportation, storage and distribution.<\/p>
<\/p>
Vaccines and vials are a precious resource in very high demand across the world and therefore for security reasons it is not possible to provide detail about the size of our supplies and exact detail about future deliveries. It should be noted that the UK has a sufficient number of glass vials available, due to orders already placed.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4336", "label" : {"_value" : "Biography information for Lord Callanan"} } , "answeringMemberPrinted" : {"_value" : "Lord Callanan"} , "dateOfAnswer" : {"_value" : "2021-02-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-03T17:46:24.607Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what was the total number of (1) Oxford/AstraZeneca, and (2) Pfizer/BioNTech, COVID-19 vaccine vials allocated to the UK held in stock in each month in (a) 2019, and (b) 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12335"} , {"_about" : "http://data.parliament.uk/resources/1278941", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1278941/answer", "answerText" : {"_value" : "
The Vaccine Manufacturing and Innovation Centre (VMIC) should be partially open in summer 2021, with the facility fully operational in 2022. The VMIC is working towards having fill-finish capability by the end of 2021. The objective remains to accelerate the readiness of the VMIC by a year and we are on track to achieve this.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4336", "label" : {"_value" : "Biography information for Lord Callanan"} } , "answeringMemberPrinted" : {"_value" : "Lord Callanan"} , "dateOfAnswer" : {"_value" : "2021-02-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-03T17:30:41.81Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccine Manufacturing and Innovation Centre"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government on what date the Vaccine Manufacturing and Innovation Centre at the Harwell Science and Innovation Campus will be fully operational for the manufacture of vaccines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12336"} , {"_about" : "http://data.parliament.uk/resources/1278942", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1278942/answer", "answerText" : {"_value" : "
The £38 million investment announced on 17 May 2020 has since been revised because it was superseded following supply agreements with vaccine candidates. Therefore, the costs were limited to the equipment and the knowledge transfer. The Government has committed £8.75 million towards the rapid deployment facility which is now operational and manufacturing the University of Oxford/AstraZeneca vaccine.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4336", "label" : {"_value" : "Biography information for Lord Callanan"} } , "answeringMemberPrinted" : {"_value" : "Lord Callanan"} , "dateOfAnswer" : {"_value" : "2021-02-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-03T17:35:46.08Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccine Manufacturing and Innovation Centre: Finance"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether their investment in the rapid deployment facility for COVID-19, announced on 17 May 2020, has been allocated; and whether the facility is operational.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12337"} , {"_about" : "http://data.parliament.uk/resources/1278943", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1278943/answer", "answerText" : {"_value" : "
The estimated vaccine production manufacturing capacity of the Vaccines Manufacturing and Innovation Centre will be up to 70 million doses of vaccine within six months, once it has opened.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4336", "label" : {"_value" : "Biography information for Lord Callanan"} } , "answeringMemberPrinted" : {"_value" : "Lord Callanan"} , "dateOfAnswer" : {"_value" : "2021-02-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-03T17:36:00.517Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccine Manufacturing and Innovation Centre"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what is the estimated vaccine production manufacturing capacity of the Vaccine Manufacturing and Innovation Centre at the Harwell Science and Innovation Campus.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12338"} , {"_about" : "http://data.parliament.uk/resources/1278944", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1278944/answer", "answerText" : {"_value" : "
Contracts between the Government and companies developing and producing COVID-19 vaccines will be published in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4336", "label" : {"_value" : "Biography information for Lord Callanan"} } , "answeringMemberPrinted" : {"_value" : "Lord Callanan"} , "dateOfAnswer" : {"_value" : "2021-02-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-03T17:27:46.46Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether they plan to publish the details of the contract they have with AstraZeneca for the supply of 30 million COVID-19 vaccine doses and vials; if so, (a) when, and (b) how; and if not, why not.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12339"} , {"_about" : "http://data.parliament.uk/resources/1278945", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1278945/answer", "answerText" : {"_value" : "
Contracts between the Government and companies developing and producing COVID-19 vaccines will be published in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4336", "label" : {"_value" : "Biography information for Lord Callanan"} } , "answeringMemberPrinted" : {"_value" : "Lord Callanan"} , "dateOfAnswer" : {"_value" : "2021-02-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-03T17:29:46.06Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "201"} , "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"} , "date" : {"_value" : "2021-01-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether they plan to publish the details of their contracts with (1) Pfizer/BioNTech for the supply of 30 million MRNA COVID-19 vaccines, (2) Janssen for the supply of 30 million doses of the AD26COV25 vaccine, (3) GSK Sanofi Pasteur for 60 million doses of the proton adjuvanted vaccine, (4) Novavax for 60 million doses of the NVXCOV2373 vaccines, and (5) Valneva for 60 million doses of the VLA2001 vaccine; if so, (a) when, and (b) how; and if not, why not.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12340"} , {"_about" : "http://data.parliament.uk/resources/1278397", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1278397/answer", "answerText" : {"_value" : "
In the 2020-21 financial year, the department provided all further education colleges and designated institutions with the Further Education Capital Allocation for addressing estate in poor condition. £200 million was allocated in total, and Askham Bryan received £845,748. The college is able to invest that funding according to the condition need identified in the department\u2019s Condition Data Collection or its own survey.<\/p>
Between the 2015-16 financial year and the present, Local Economic Partnerships have had devolved responsibility for allocating skills capital funding via the Local Growth Fund. There is no record of funding for the Newton Rigg campus.<\/p>
Before 2015, capital funding for colleges was the responsibility of the Skills Funding Agency. In the 2014-15 financial year, a grant of £139,593 was paid to Askham Bryan College. There is no record as to whether any part of that funding was used in relation to Newton Rigg campus<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4218", "label" : {"_value" : "Biography information for Baroness Berridge"} } , "answeringMemberPrinted" : {"_value" : "Baroness Berridge"} , "dateOfAnswer" : {"_value" : "2021-02-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-01T17:02:04.9Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2021-01-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Newton Rigg College: Askham Bryan College"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government how much they have paid in grants to Askham Bryan College for the development of assets and projects relating to the Newton Rigg estate in each of the last seven years; and for which projects any such grants were provided.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12274"} , {"_about" : "http://data.parliament.uk/resources/1277341", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1277341/answer", "answerText" : {"_value" : "
The Newton Rigg Strategic Review process has been extended. The Further Education Commissioner team and Education and Skills Funding Agency officials are continuing to work closely with stakeholders, including Askham Bryan College, to try and find a solution for retaining some or all of the education provision on the Newton Rigg campus.<\/p>
Askham Bryan College is independent of the government and is responsible for any decision on Newton Rigg and the associated financial implications.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4218", "label" : {"_value" : "Biography information for Baroness Berridge"} } , "answeringMemberPrinted" : {"_value" : "Baroness Berridge"} , "dateOfAnswer" : {"_value" : "2021-02-01", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL12196"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-01T12:27:39.007Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2021-01-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Newton Rigg College"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what plans they have to publish the report of the Newton Rigg Strategic Review undertaken by the Further Education Commissioner Team and which concluded in December 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12195"} , {"_about" : "http://data.parliament.uk/resources/1277342", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1277342/answer", "answerText" : {"_value" : "
The Newton Rigg Strategic Review process has been extended. The Further Education Commissioner team and Education and Skills Funding Agency officials are continuing to work closely with stakeholders, including Askham Bryan College, to try and find a solution for retaining some or all of the education provision on the Newton Rigg campus.<\/p>
Askham Bryan College is independent of the government and is responsible for any decision on Newton Rigg and the associated financial implications.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4218", "label" : {"_value" : "Biography information for Baroness Berridge"} } , "answeringMemberPrinted" : {"_value" : "Baroness Berridge"} , "dateOfAnswer" : {"_value" : "2021-02-01", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL12195"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-01T12:27:39.05Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2021-01-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Newton Rigg College: Askham Bryan College"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what discussions they have had with the Further Education Commissioner Team that undertook the (1) Newton Rigg Strategic Review, and (2) Newton Rigg Review, about publishing any financial planning proposals by Askham Bryan College relating to the viability and future of Newton Rigg college in Penrith.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL12196"} , {"_about" : "http://data.parliament.uk/resources/1275482", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1275482/answer", "answerText" : {"_value" : "
Public Health England (PHE) is responsible for the central storage and distribution of ultra-low temperature COVID-19 vaccines. In its preparations to receive vaccines, PHE determined the freezer capacity requirement to support the United Kingdom programme during summer 2020 and secured the freezers against that requirement. These were commissioned and in service before arrival of the vaccine. They provide sufficient storage for approximately five million doses of COVID-19 vaccines which require minus 60 degree Celsius storage or below.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2021-02-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-02-01T12:43:26.72Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-01-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what (1) estimate they made, and (2) audit they undertook, of the potential (a) demand, and (b) availability, of sub-60 degree freezer capacity in the UK prior to the Pfizer COVID-19 vaccine rollout in 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL11968"} ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Lord+Campbell-Savours&_page=1&max-AnswerDate=2021-02-03&houseId=2®isteredInterest=false&min-ddpModified.=2021-02-01T12%3A59%3A15.934Z", "page" : 0, "startIndex" : 1, "totalResults" : 20, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }